Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gsell

Showing results (331-340 of 338) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 338 results.
Journal of Medical Internet Research|May 2, 2024
IT-Related Barriers and Facilitators to the Implementation of a New European eHealth Solution, the Digital Survivorship Passport (SurPass Version 2.0): Semistructured Digital SurveyIsmay A E de Beijer, Selina R van den Oever, Eliana Charalambous, et al.
Journal of Cancer Survivorship : Research and Practice|February 22, 2023
Barriers and facilitators to implementation of the interoperable Survivorship Passport (SurPass) v2.0 in 6 European countries: a PanCareSurPass online survey studySelina R van den Oever, Ismay A E de Beijer, Leontien C M Kremer, et al.
Cancer Medicine|September 18, 2024
Barriers, facilitators, and other factors associated with health behaviors in childhood, adolescent, and young adult cancer survivors: A systematic reviewIsmay A E de Beijer, Eline Bouwman, Renée L Mulder, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 13, 2025
Vaccination strategies for Ebola in the democratic republic of Congo: the WHO-Ebola modeling collaborationMarco Ajelli, Jean-Jacques Muyembe, Alhassane Touré, et al.
BMC Medicine|November 7, 2024
rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches)Conall H Watson, Pierre-Stéphane Gsell, Yper Hall, et al.
Nature|December 22, 2021
Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not BetaLorenz Ulrich, Nico Joel Halwe, Adriano Taddeo, et al.
Nature Immunology|May 26, 2022
Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammationLidia Yshii, Emanuela Pasciuto, Pascal Bielefeld, et al.
Nature|September 23, 2020
Animal models for COVID-19César Muñoz-Fontela, William E Dowling, Simon G P Funnell, et al.
Pageof 34

Showing results (331-340 of 338) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 338 results.
Journal of Medical Internet Research|May 2, 2024
IT-Related Barriers and Facilitators to the Implementation of a New European eHealth Solution, the Digital Survivorship Passport (SurPass Version 2.0): Semistructured Digital SurveyIsmay A E de Beijer, Selina R van den Oever, Eliana Charalambous, et al.
Journal of Cancer Survivorship : Research and Practice|February 22, 2023
Barriers and facilitators to implementation of the interoperable Survivorship Passport (SurPass) v2.0 in 6 European countries: a PanCareSurPass online survey studySelina R van den Oever, Ismay A E de Beijer, Leontien C M Kremer, et al.
Cancer Medicine|September 18, 2024
Barriers, facilitators, and other factors associated with health behaviors in childhood, adolescent, and young adult cancer survivors: A systematic reviewIsmay A E de Beijer, Eline Bouwman, Renée L Mulder, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 13, 2025
Vaccination strategies for Ebola in the democratic republic of Congo: the WHO-Ebola modeling collaborationMarco Ajelli, Jean-Jacques Muyembe, Alhassane Touré, et al.
BMC Medicine|November 7, 2024
rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches)Conall H Watson, Pierre-Stéphane Gsell, Yper Hall, et al.
Nature|December 22, 2021
Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not BetaLorenz Ulrich, Nico Joel Halwe, Adriano Taddeo, et al.
Nature Immunology|May 26, 2022
Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammationLidia Yshii, Emanuela Pasciuto, Pascal Bielefeld, et al.
Nature|September 23, 2020
Animal models for COVID-19César Muñoz-Fontela, William E Dowling, Simon G P Funnell, et al.
Pageof 34